Synthetic nanoparticles for the delivery of CRISPR/Cas9 gene editing system: classification and biomedical applications

Qi Zheng, Weitao Wang, Yuhang Zhou, Jiayin Mo, Xinyue Chang, Zhengbao Zha and Lisha Zha

Biomater. Sci., 2023, 11, 5361
DOI: 10.1039/D3BM00788J

Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR/Cas9 gene editing system delivery

Panqin Ma, Qi Wang, Xi Luo, Liuzhou Mao, Zhanxiang Wang, Enyi Ye, Xian Jun Loh, Zibiao Li and Yun-Long Wu

Biomater. Sci., 2023, 11, 5078
DOI: 10.1039/D3BM00529A

Nanotechnological approaches for the targeted delivery of CRISPR-Cas systems for genomic modifications, biomolecular sensing, and precision medicine

Mirza Muhammad Faran Ashraf Baig, Wai Tong Chien and Sek Ying Chair

Biomater. Sci., 2025, 13, 4597
DOI: 10.1039/D5BM00711A

Emerging lipid–polymer hybrid nanoparticles for genome editing

Mariana Gameiro, João F. Mano and Vítor M. Gaspar

Polym. Chem., 2024, 15, 3436
DOI: 10.1039/D4PY00298A

Development of Inorganic and Hybrid Nanosystems for Delivery of CRISPR-Based Gene Editors

Iulia Spataru, Felix Mahoro and Ildiko Badea

Mol. Pharmaceutics, 2025, 22, 4373
DOI: 10.1021/acs.molpharmaceut.5c00251

pH‐Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA

Ruosen Xie, Xiuxiu Wang, Yuyuan Wang, Mingzhou Ye, Yi Zhao, Brian S. Yandell and Shaoqin Gong

Advanced Materials, 2022, 34
DOI: 10.1002/adma.202110618

Nose to brain delivery of selegiline loaded PLGA/lipid nanoparticles: Synthesis, characterisation and brain pharmacokinetics evaluation

Subashini Raman, Arshad Ali Khan and Syed Mahmood

Journal of Drug Delivery Science and Technology, 2022, 77, 103923
DOI: 10.1016/j.jddst.2022.103923

Functionally Tunable Star‐Shaped Multivalent crRNAs for Photocontrol CRISPR/Cas Editing

Wen‐Da Chen, Li Liu and Liang Cheng

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202506527

Pressure-Biased Nanopores for Excluded Volume Metrology, Lipid Biomechanics, and Cell-Adhesion Rupturing

Vinay Sharma and Kevin J. Freedman

ACS Nano, 2021, 15, 17947
DOI: 10.1021/acsnano.1c06393

Topology‐Engineered Guide RNAs for Programmable Control of CRISPR/Cas Activity

Liang Cheng

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202511756

Functionally Tunable Star‐Shaped Multivalent crRNAs for Photocontrol CRISPR/Cas Editing

Wen‐Da Chen, Li Liu and Liang Cheng

Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202506527

Tumor microenvironment based stimuli-responsive CRISPR/Cas delivery systems: A viable platform for interventional approaches

Nanyang Tang, Qian Ning, Zewei Wang, Yifang Tao, Xuhong Zhao and Shengsong Tang

Colloids and Surfaces B: Biointerfaces, 2022, 210, 112257
DOI: 10.1016/j.colsurfb.2021.112257

CRISPR/Cas9 in Cancer Therapy: Precision Genome Editing Approaches Targeting Hematological Malignancies and Solid Tumors Through Cellular, Biochemical, and Molecular Mechanisms

Disha Joshi, Prachi Kshatri, Aayush Tiwari, Umang Bhardwaj and Kaushika Patel

Cell Biochem Biophys, 2026
DOI: 10.1007/s12013-026-02015-1

Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier

Ruosen Xie, Yuyuan Wang, Jacobus C. Burger, Dongdong Li, Min Zhu and Shaoqin Gong

Med-X, 2023, 1
DOI: 10.1007/s44258-023-00004-0

Topology‐Engineered Guide RNAs for Programmable Control of CRISPR/Cas Activity

Liang Cheng

Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202511756

Innovative approaches to combat antibiotic resistance: integrating CRISPR/Cas9 and nanoparticles against biofilm-driven infections

Abolfazl Saffari Natanzi, Mohsen Poudineh, Elham Karimi, Azad Khaledi and Hamed Haddad Kashani

BMC Med, 2025, 23
DOI: 10.1186/s12916-025-04323-4

Next-Generation Transformable Nanomedicines: Revolutionizing Cancer Drug Delivery and Theranostics

Swapnil Shinde, Saurabh Shah, Paras Famta, Suraj Wagh, Giriraj Pandey, Abhishek Sharma, Ganesh Vambhurkar, Akshita Jain and Saurabh Srivastava

Mol. Pharmaceutics, 2025, 22, 2783
DOI: 10.1021/acs.molpharmaceut.4c01495

Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method

Abhiroop Sengupta, Parasmita Saha, Ritama Chakraborty, Arnab K. Maiti, Soumya Chakraborty, Aparna Datta and Ananda S. Datta

Apoptosis, 2026, 31
DOI: 10.1007/s10495-026-02281-7